Columbus, Ohio – October 23, 2025 – The BodyGNTX Institute of Biomechanics & Movement Performance, in direct collaboration with the MMSx Authority, today released the highly anticipated findings from the Movement-Oriented Velocity of Engagement (MOVE) Protocol study (NCT07220200). As a co-funding partner and a key U.S. research site, BodyGNTX played an integral role in this landmark international study, which provides definitive evidence for a paradigm shift away from passive rest and toward early, structured mobilization for musculoskeletal pain.
The prospective, multi-site case-series, which began in June 2024, evaluated a cohort of 40 participants across four sites in the U.S. and India. The study confirms that the MOVE protocol significantly reduces pain, restores function, and accelerates return-to-activity timelines with an exceptional safety profile. BodyGNTX was instrumental in this success, managing the recruitment and protocol implementation for 8 U.S.-based participants under the expert guidance of Site Principal Investigator Dr. John Davis, DPT, OCS.
This research, conceived and led by BodyGNTX and MMSx Authority founder Dr. Neeraj Mehta, Ph.D., directly challenges conventional wisdom by demonstrating that the body’s healing processes are optimally stimulated through precise, progressive mechanical loading.
“For decades, the science has pointed toward the limitations of prolonged rest, yet clinical practice has been slow to evolve. The MOVE Protocol was designed to bridge that gap,” stated Dr. Neeraj Mehta. “This study is not merely about a set of exercises; it is about the systematic application of biomechanical and physiological principles—mechanotransduction, neural validation, and metabolic optimization. BodyGNTX was founded on these principles, and we are proud to have validated them in a rigorous, multi-site clinical setting. We have provided the evidence; now, we will lead the change in application.”
The Scientific Architecture of the MOVE Protocol
The MOVE Protocol is a four-phase framework that systematically guides a patient from injury to full functional recovery. It is built on a deep understanding of tissue biology, motor control, and bioenergetics.
•M – Mobilize Early: This initial phase utilizes pain-free active range of motion and gentle joint oscillations. The goal is to stimulate mechanotransduction—the process by which cells convert mechanical stimuli into biochemical activity—to promote tissue repair and reduce the inflammatory stasis caused by immobility.
•O – Optimize Load: Moving beyond simple movement, this phase introduces carefully dosed isometric, and then isotonic, loads. This progressive loading is critical for organizing collagen fiber alignment, building tissue resilience, and enhancing force production capacity without provoking symptom flare-ups.
•V – Validate Neural Control: Pain and injury often lead to proprioceptive deficits and dysfunctional movement patterns. This phase directly targets the central nervous system with balance, perturbation, and coordination drills to restore stable motor control and rebuild the brain-body connection.
•E – Energize Recovery: The final phase incorporates low-intensity cardiovascular work to enhance systemic circulation, improve heart rate recovery, and build the metabolic foundation necessary to support a full return to activity. This ensures the entire biological system is primed for performance.
BodyGNTX Site: Precision in Execution
The BodyGNTX site in Powell, Ohio, was a model of clinical precision. Under the leadership of Dr. John Davis and Study Coordinator Sarah Chen, B.S., CCRP, the team meticulously implemented the protocol for its 8 participants, ensuring high fidelity to the study’s rigorous SOPs and contributing clean, reliable data to the central analysis unit at MMSx Authority.
Comprehensive Clinical Outcomes
The aggregated data from all 40 participants paint a clear picture of the protocol’s efficacy. The results represent a significant leap forward for musculoskeletal rehabilitation.
| Outcome Measure | Average Improvement (Δ Week 8) |
| Pain Reduction (NRS Score) | -5.1 points (Exceeding Clinical Significance) |
| Functional Improvement (LEFS/UEFI) | +27.4 points (Major Functional Restoration) |
| Balance (Single-Leg Stance) | +13.4 seconds |
| Functional Strength (30-s Sit-to-Stand) | +6.3 repetitions |
Remarkably, participants achieved a median return-to-daily-activities in just 14 days, with zero serious adverse events reported across the entire study. This combination of speed and safety validates the MOVE protocol as a superior alternative to traditional, rest-heavy approaches.
[Graph 1: Pie chart illustrating the participant distribution by site, highlighting the BodyGNTX (8 participants) and MMSx (7 participants) U.S. cohorts.]
[Graph 2: Line graph showing the functional improvement (LEFS/UEFI) over 8 weeks for the BodyGNTX cohort, demonstrating rapid progress.]
Translating Research into Practice
As both a research leader and an educational body, BodyGNTX is uniquely positioned to translate these findings into actionable clinical tools. The MOVE Protocol will be integrated into all BodyGNTX and MMSx Authority certification pathways, ensuring that the next generation of movement professionals is armed with the most effective, evidence-based strategies for pain management and performance restoration.
This study represents a core validation of the BodyGNTX philosophy: that a deep understanding of biomechanics and movement science is the key to unlocking human potential. The MOVE Protocol provides a clear, replicable system for achieving this, and BodyGNTX is proud to have been at the heart of its development and validation.
About BodyGNTX Fitness Institute: BodyGNTX is a premier institute for biomechanics and movement performance, dedicated to advancing human function through the scientific application of movement mechanics. Founded by Dr. Neeraj Mehta, BodyGNTX provides elite education, certifications, and clinical tools for professionals seeking to master the art and science of movement. Learn more at bodygntx.com.
About MMSx Authority: The MMSx Authority Institute for Movement Mechanics and Biomechanics Research is a leading global organization dedicated to advancing the science of human movement. Through research, education, and the development of standardized protocols, MMSx is setting a new standard for performance and rehabilitation. Learn more at mmsxauthority.com.
References:
1.ClinicalTrials.gov. (2025). A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery. NCT07220200. https://clinicaltrials.gov/study/NCT07220200
2.Mehta, N., et al. (2025). MOVE-001/2025 Clinical Study Protocol. MMSx Authority Institute for Movement Mechanics & Biomechanics Research. Version 1.0, June 15, 2024.
1. Dubois B, Esculier JF. Soft-tissue injuries simply need PEACE and LOVE. British Journal of Sports Medicine. 2020;54:72-73.
https://bjsm.bmj.com/content/54/2/72
2. Singh DP, Barani Lonbani Z, Woodruff MA, Parker TJ, Steck R, Peake JM. Effects of Topical Icing on Inflammation, Angiogenesis, Revascularization, and Myofiber Regeneration in Skeletal Muscle Following Contusion Injury. Frontiers in Physiology. 2017;8:93.
https://www.frontiersin.org/articles/10.3389/fphys.2017.00093/full
3. Khan KM, Scott A. Mechanotherapy: how physical therapists’ prescription of exercise promotes tissue repair. British Journal of Sports Medicine. 2009;43:247-252.
https://bjsm.bmj.com/content/43/4/247
4. McAuley JH, et al. Minimal clinically important difference in pain and function outcomes. (context for graded loading) Journal of Pain. 2014;15(3):264-71.
5. Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. Physical Therapy. 1999;79(4):371-83.
6. International Council for Harmonisation. ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). 2016.
https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf
7. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 2013.